Who
Anat Hakim
EVP, GC & Secretary
Company insider
Files Form 4 as: EVP, GC & Secretary, Eli Lilly and; EVP, General Counsel/Secretary, Wellcare Health Plans.
In numbers
- Trades disclosed
- 78
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $19.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 6 Feb 2017
- Last trade
- 2 Nov 2026
- Last filed
- 3 Nov 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Nov 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Nov 2026filed 3 Nov 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $7.0M5,000 at $1,402.52 | filing |
| 7 Aug 2026filed 10 Aug 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $6.0M5,000 at $1,190.00 | filing |
| 7 Aug 2026filed 10 Aug 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $6.0M5,000 at $1,190.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $8.6M8,277.919 at $1,044.67 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $8.6M8,277.92 at $1,044.67 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —6,700 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $3.1M2,953.395 at $1,037.15 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,700 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,700 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —6,700 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $3.1M2,953.4 at $1,037.15 | filing |
| 2 May 2025filed 5 May 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —17,875 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,700 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $9.0M10,320.96 at $868.88 | filing |
| 1 Feb 2025filed 4 Feb 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,904 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —4,904 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $1.8M2,166.46 at $811.08 | filing |
| 12 Aug 2024filed 13 Aug 2024 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —14,700 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,904 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $4.3M5,815 at $737.26 | filing |
News
Eli Lilly and Company (NYSE:LLY) EVP Anat Hakim Sells 5,000 Shares of Company Stockthemarketsdaily.com · 3 Nov 2026Eli Lilly and Company (NYSE:LLY) EVP Anat Hakim Sells 5,000 Shares of Company StockLLY · themarketsdaily.com · 3 Nov 2026450 Eli Lilly and Company $LLY Shares Purchased by Vigilare Wealth ManagementLLY · dailypolitical.com · 3 Nov 2026Trek Financial LLC Buys 380 Shares of Eli Lilly and Company $LLYLLY · dailypolitical.com · 3 Nov 2026
1 headline in the last 90 days name Anat Hakim; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.